BPC-157 helps your body lay that scaffolding faster, tighter, and stronger
Every patient gets physician consultation, a personalized treatment plan, and ongoing monitoring, all coordinated online
Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent
Finally, BPC-157 is most likely to be considered as an adjunctive treatment, not a one-size-fits-all treatment, but rather a part of a comprehensive wellness program designed to help improve mobility, comfort, and quality of life, particularly in aging or recovering dogs.
Published findings concerning body composition, glucose regulation, liver pathology and muscle function come from laboratory and animal studies rather than established human clinical trials
